Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Androctonus australis hector (Aah) alpha-toxins are a group of highly potent neurotoxic peptides found in the venom of the North African scorpion. These toxins, particularly the well-studied Aah II, are the primary drivers of toxicity in humans following envenomation (UniProt: P01490). They function by binding with high affinity to neurotoxin receptor site 3 on voltage-gated sodium (Nav) channels, primarily in the nervous and muscular systems (Cestèle & Catterall, 2000). This binding slows the inactivation of the sodium channel, leading to prolonged depolarization and repetitive firing of action potentials, which manifests clinically as an autonomic storm involving massive release of catecholamines and acetylcholine (Martin-Eauclaire et al., 2019). Because of their lethal potency, these toxins are the primary targets for the development of therapeutic antivenoms and next-generation neutralizing agents like nanobodies. Understanding their structure-function relationship is critical for designing effective treatments against scorpionism in endemic regions.
The toxins bind to neurotoxin receptor site 3 on the extracellular loops of voltage-gated sodium channels (Nav), specifically hindering the movement of the S4 segment in domain IV. This action slows the inactivation process of the channel, leading to prolonged sodium influx and persistent depolarization of excitable cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Androctonus australis hector alpha-toxin (Aah alpha-toxin) (Aah alpha-toxin).